Therapy areas
We know the science. And the people it affects.
More than 70 therapy areas across 300+ brands. Some of our experience runs especially deep, and it shows in the questions we ask before we write a word.
- brands
- 300+brands
- brand launches
- 50+brand launches
- therapy areas
- 70+therapy areas
- completed projects
- 1,000+completed projects
Where we go deepest
The harder the science, the more we enjoy it.
This is where our experience runs deepest. Each area has its own language, its own specialists and its own reasons why a message lands or doesn't.
Oncology and haematology
Why it’s hardFast-moving data, complex mechanisms and treatment decisions with very high stakes.
What we’ve worked onCAR-T and cell therapy launches, leukaemias, lymphomas, myeloma, breast, lung and prostate cancer.
Immunology
Why it’s hardMany treatment options, and patients who have often tried several already.
What we’ve worked onCrohn's and ulcerative colitis, lupus, psoriatic and rheumatoid arthritis, HLH.
Neurology
Why it’s hardLong journeys, outcomes that are hard to measure and carers who are part of every decision.
What we’ve worked onMultiple sclerosis, Parkinson's, Alzheimer's, epilepsy, migraine, post-stroke spasticity.
Rare disease
Why it’s hardSmall populations, few specialists and every word under scrutiny.
What we’ve worked onGaucher disease, acromegaly, primary HLH, beta thalassaemia, haemophilia.
Medical devices
Why it’s hardAudiences who buy on evidence and technique, not mechanism of action.
What we’ve worked onBiosurgery, fibrin sealants, haemostatic matrices, surgery and wound care.
Who we talk to
We know who’s on the other side of the message.
- Specialist doctors. Busy, sceptical and fluent in the data. We respect their time and their intelligence.
- Nurses and pharmacists. Often the people who make treatment work day to day.
- Payers and market access. Our founder worked in market access at Novartis, so value stories are second nature.
- Patients and carers. People first, diagnosis second.
- Your own teams. Sales and medical colleagues who need to understand the story before they can tell it.
Global, regional, local
One idea. Many markets.
We work at global, regional and local level, including emerging markets. With teams in the UK and Copenhagen, we know how a global idea needs to change to work in a local market, and how to keep it approved along the way.
Specialist knowledge
- Rare disease
- Biosimilars
- Brand substitution
- Generics
- Multi-indication therapies
The full list
18 specialisms. 70+ therapy areas.
Search by condition, treatment or abbreviation.
18 specialisms covering 70+ therapy areas
Cardiovascular
Hypertension, Surgery, Diabetes
Dermatology
Psoriasis, Eczema, Actinic Keratosis, Fungal Nail & Skin Infections
Endocrinology
Interventional, Acromegaly, GHD (growth hormone deficiency), Hyperhidrosis
Haematology
Beta Thalassemia, Haemophilia, Stem Cell Mobilisation, ALCL, AML, APML, CLL, CML, DLBCL, FL, HL, MM
Hepatic
Hepatitis B, Hepatitis C
Immunology
Crohn's & UC (ulcerative colitis), HLH, Lupus, Psoriatic Arthritis, Rheumatoid Arthritis
Got a brief in one of these areas?
Tell us the challenge. We'll put the right people around it.
Start a conversation